|
|
|
|
|
|
|
|
 Thursday's market movers including ValiRx |
|
Dato: 13/06/2013 06:52 - Per: bambaec - 70 Vidoj - Kategorio: Diversaj
The firm has agreed an expanded protocol for its first-in-man studies on VAL 201 - the drug candidate being developed for prostate cancer\nLON:BAO
|
|
Komentoj... |
|
Rilataj videoj... |
|
|
|
|
|
|
|
|
|
|
Esperanto 
